Abstract

The Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has highlighted the need for performing accurate inference with limited data. Fundamental to the design of rapid state responses is the ability to perform epidemiological model parameter inference for localised trajectory predictions. In this work, we perform Bayesian parameter inference using Markov Chain Monte Carlo (MCMC) methods on the Susceptible-Infected-Recovered (SIR) and Susceptible-Exposed-Infected-Recovered (SEIR) epidemiological models with time-varying spreading rates for South Africa. The results find two change points in the spreading rate of COVID-19 in South Africa as inferred from the confirmed cases. The first change point coincides with state enactment of a travel ban and the resultant containment of imported infections. The second change point coincides with the start of a state-led mass screening and testing programme which has highlighted community-level disease spread that was not well represented in the initial largely traveller based and private laboratory dominated testing data. The results further suggest that due to the likely effect of the national lockdown, community level transmissions are slower than the original imported case driven spread of the disease.

Highlights

  • The first reported case of the novel coronavirus (SARS-CoV-2) in South Africa was announced on 5 March 2020, following the initial manifestation of the virus in Wuhan China in December 2019 [1,2,3]

  • We introduce the SusceptibleExposed-Infectious-Recovered (SEIR) and the related Susceptible-Infectious-Recovered (SIR) compartmental models that have been dominant in COVID-19 modelling literature [1, 5, 6, 10]

  • SIR and SEIR model parameter inference was performed using confirmed cases data up to and including 20 April 2020 and Markov Chain Monte Carlo (MCMC) samplers described in the methodology section

Read more

Summary

Introduction

The first reported case of the novel coronavirus (SARS-CoV-2) in South Africa was announced on 5 March 2020, following the initial manifestation of the virus in Wuhan China in December 2019 [1,2,3]. Numerous states have attempted to minimise the growth in number of COVID-19 infections [1, 5, 6]. These attempts are largely based on non-pharmaceutical interventions (NPIs) aimed at separating the infectious population from the susceptible population [1]. These initiatives aim to strategically reduce the increase in infections to a level where their healthcare systems stand a chance of minimising the number of fatalities [1].

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call